Podchaser Logo
Home
Sustainable Edge: How impact investing can transform global health challenges. A conversation with Nina Rawal

Sustainable Edge: How impact investing can transform global health challenges. A conversation with Nina Rawal

Released Tuesday, 21st May 2024
Good episode? Give it some love!
Sustainable Edge: How impact investing can transform global health challenges. A conversation with Nina Rawal

Sustainable Edge: How impact investing can transform global health challenges. A conversation with Nina Rawal

Sustainable Edge: How impact investing can transform global health challenges. A conversation with Nina Rawal

Sustainable Edge: How impact investing can transform global health challenges. A conversation with Nina Rawal

Tuesday, 21st May 2024
Good episode? Give it some love!
Rate Episode

In this episode of Sustainable Edge, our host Joachim Nahem is accompanied by Nina Rawal, Partner at Trill Impact Advisory and Co-Head of Impact Ventures. They delve into the challenges and opportunities in impact investing, the role of venture capital in driving innovation, and the importance of measuring impact through frameworks like the theory of change. Nina emphasizes the need for transformative technologies to address health inequalities and improve access to healthcare globally. Listen in to hear about the transformative potential of impact investing.

Key Learning from this episode:

  • Listen to innovative examples of how impact investments are making a difference

  • Learn about the frameworks and metrics used to ensure that investments are not only profitable but also create measurable social impact 

  • Discover how venture capital is pioneering advancements in therapeutics, vaccines, diagnostics, and medical devices, with a special focus on historically overlooked geographies


About Nina Rawal:

Nina Rawal, Partner at Trill Impact Advisory and Co-Head of Impact Ventures, brings extensive experience from leadership roles at Industrifonden and Gambro, alongside consulting with Boston Consulting Group. With an academic background in Biomedicine and Molecular Neurobiology from Karolinska Institutet, her contributions extend to serving on boards like Cinclus Pharma and Stockholms Sjukhem, earning recognition as a Young Global Leader by the World Economic Forum.

 

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features